{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T04:37:03Z","timestamp":1794199023757,"version":"4.8.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04649-0","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T03:05:26Z","timestamp":1769569526000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Associations of relative fat mass with metabolic dysfunction\u2013associated steatotic liver disease and liver fibrosis: evidence from the U.S. NHANES 2017\u20132023"],"prefix":"10.1186","volume":"26","author":[{"given":"Hai-Yuan","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Dan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Cheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Mei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Yu","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"4649_CR1","doi-asserted-by":"publisher","unstructured":"Younossi ZM, Kalligeros M, Henry L, Suppl. S32\u201350. https:\/\/doi.org\/10.3350\/cmh.2024.0431.","DOI":"10.3350\/cmh.2024.0431"},{"key":"4649_CR2","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/ncp.10449","volume":"35","author":"MS Mundi","year":"2020","unstructured":"Mundi MS, Velapati S, Patel J, Kellogg TA, Abu Dayyeh BK, Hurt RT. Evolution of NAFLD and its management. Nutr Clin Pract. 2020;35:72\u201384. https:\/\/doi.org\/10.1002\/ncp.10449.","journal-title":"Nutr Clin Pract"},{"key":"4649_CR3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/carcin\/19.1.195","volume":"19","author":"MA Shibata","year":"1998","unstructured":"Shibata MA, Jorcyk CL, Devor DE, Yoshidome K, Rulong S, Resau J, et al. Altered expression of transforming growth factor betas during urethral and bulbourethral gland tumor progression in Transgenic mice carrying the androgen-responsive C3(1) 5\u2019 flanking region fused to SV40 large T antigen. Carcinogenesis. 1998;19:195\u2013205. https:\/\/doi.org\/10.1093\/carcin\/19.1.195.","journal-title":"Carcinogenesis"},{"key":"4649_CR4","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ejim.2025.02.014","volume":"134","author":"J Boeckmans","year":"2025","unstructured":"Boeckmans J, Widman L, Shang Y, Strandberg R, Wester A, Schattenberg JM, et al. Risk of hepatic decompensation or HCC is similar in patients with ALD- and MASLD-cirrhosis: A population-based cohort study. Eur J Intern Med. 2025;134:104\u201313. https:\/\/doi.org\/10.1016\/j.ejim.2025.02.014.","journal-title":"Eur J Intern Med"},{"key":"4649_CR5","doi-asserted-by":"publisher","first-page":"1433857","DOI":"10.3389\/fcell.2024.1433857","volume":"12","author":"R Sandireddy","year":"2024","unstructured":"Sandireddy R, Sakthivel S, Gupta P, Behari J, Tripathi M, Singh BK. Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases. Front Cell Dev Biol. 2024;12:1433857. https:\/\/doi.org\/10.3389\/fcell.2024.1433857.","journal-title":"Front Cell Dev Biol"},{"key":"4649_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s13679-025-00641-z","volume":"14","author":"A De Lorenzo","year":"2025","unstructured":"De Lorenzo A, Gualtieri P, Frank G, Palma R, Cianci R, Romano L, et al. Normal weight obesity overview and update: A narrative review. Curr Obes Rep. 2025;14:50. https:\/\/doi.org\/10.1007\/s13679-025-00641-z.","journal-title":"Curr Obes Rep"},{"key":"4649_CR7","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1038\/s41366-021-00858-7","volume":"45","author":"NN Wijayatunga","year":"2021","unstructured":"Wijayatunga NN, Dhurandhar EJ. Normal weight obesity and unaddressed cardiometabolic health risk-a narrative review. Int J Obes (Lond). 2021;45:2141\u201355. https:\/\/doi.org\/10.1038\/s41366-021-00858-7.","journal-title":"Int J Obes (Lond)"},{"key":"4649_CR8","doi-asserted-by":"publisher","first-page":"e0122985","DOI":"10.1371\/journal.pone.0122985","volume":"10","author":"BCC Lam","year":"2015","unstructured":"Lam BCC, Koh GCH, Chen C, Wong MTK, Fallows SJ. Comparison of body mass index (BMI), body adiposity index (BAI), waist circumference (WC), waist-To-Hip ratio (WHR) and waist-To-Height ratio (WHtR) as predictors of cardiovascular disease risk factors in an adult population in Singapore. PLoS ONE. 2015;10:e0122985. https:\/\/doi.org\/10.1371\/journal.pone.0122985.","journal-title":"PLoS ONE"},{"key":"4649_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ejim.2022.12.024","volume":"109","author":"N Suthahar","year":"2023","unstructured":"Suthahar N, Wang K, Zwartkruis VW, Bakker SJL, Inzucchi SE, Meems LMG, et al. Associations of relative fat mass, a new index of adiposity, with type-2 diabetes in the general population. Eur J Intern Med. 2023;109:73\u20138. https:\/\/doi.org\/10.1016\/j.ejim.2022.12.024.","journal-title":"Eur J Intern Med"},{"key":"4649_CR10","doi-asserted-by":"publisher","first-page":"10980","DOI":"10.1038\/s41598-018-29362-1","volume":"8","author":"OO Woolcott","year":"2018","unstructured":"Woolcott OO, Bergman RN. Relative fat mass (RFM) as a new estimator of whole-body fat percentage A cross-sectional study in American adult individuals. Sci Rep. 2018;8:10980. https:\/\/doi.org\/10.1038\/s41598-018-29362-1.","journal-title":"Sci Rep"},{"key":"4649_CR11","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/s41430-024-01464-2","volume":"78","author":"C Aguirre","year":"2024","unstructured":"Aguirre C, Tumani MF, Carrasco F, Inostroza J, Obreg\u00f3n AM, Reyes \u00c1, et al. Relative fat mass as an estimator of body fat percentage in Chilean adults. Eur J Clin Nutr. 2024;78:782\u20137. https:\/\/doi.org\/10.1038\/s41430-024-01464-2.","journal-title":"Eur J Clin Nutr"},{"key":"4649_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/XCE.0000000000000176","volume":"8","author":"O Kobo","year":"2019","unstructured":"Kobo O, Leiba R, Avizohar O, Karban A. Relative fat mass is a better predictor of dyslipidemia and metabolic syndrome than body mass index. Cardiovasc Endocrinol Metab. 2019;8:77\u201381. https:\/\/doi.org\/10.1097\/XCE.0000000000000176.","journal-title":"Cardiovasc Endocrinol Metab"},{"key":"4649_CR13","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1186\/s12876-025-04006-7","volume":"25","author":"J Wang","year":"2025","unstructured":"Wang J, He W, Cai X, Hu Z, Peng Y, Chen X, et al. Relative fat mass and risk of metabolic dysfunction associated steatotic liver disease and severe hepatic steatosis in U.S. Adults: analysis of NHANES 2017\u20132020 data. BMC Gastroenterol. 2025;25:410. https:\/\/doi.org\/10.1186\/s12876-025-04006-7.","journal-title":"BMC Gastroenterol"},{"key":"4649_CR14","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1053\/j.gastro.2025.02.034","volume":"169","author":"W-Y Liu","year":"2025","unstructured":"Liu W-Y, Huang S, Ji H, Kim SU, Yip TC-F, Wong GL-H, et al. From Burnt-Out to Burning-Out: capturing liver fat loss in patients with advanced metabolic Dysfunction-Associated steatotic liver disease from a dynamic perspective. Gastroenterology. 2025;169:326\u2013e3364. https:\/\/doi.org\/10.1053\/j.gastro.2025.02.034.","journal-title":"Gastroenterology"},{"key":"4649_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/joim.20103","volume":"298","author":"W Balkhed","year":"2025","unstructured":"Balkhed W, Bergram M, Iredahl F, Holmberg M, Edin C, Carlh\u00e4ll C-J, et al. Evaluating the prevalence and severity of metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus in primary care. J Intern Med. 2025;298:173\u201387. https:\/\/doi.org\/10.1111\/joim.20103.","journal-title":"J Intern Med"},{"key":"4649_CR16","first-page":"1","volume":"1","author":"G Zipf","year":"2013","unstructured":"Zipf G, Chiappa M, Porter KS, Ostchega Y, Lewis BG, Dostal J. National health and nutrition examination survey: plan and operations, 1999\u20132010. Vital Health Stat. 2013;1:1\u201337.","journal-title":"Vital Health Stat"},{"key":"4649_CR17","unstructured":"McQuillan GM, McLean JE, Chiappa M, Corporation H, Lukacs SL. National health and nutrition examination survey biospecimen program: NHANES III (1988\u20131994) and NHANES 1999\u20132014. Vital Health Stat 2. 2015;:1\u201314."},{"key":"4649_CR18","unstructured":"National Health and Nutrition Examination Survey | National Health and Nutrition Examination Survey | CDC. https:\/\/www.cdc.gov\/nchs\/nhanes\/index.html. Accessed 9 Dec 2025."},{"key":"4649_CR19","unstructured":"EASL-EASD-EASO. Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). PubMed."},{"key":"4649_CR20","volume-title":"Metabolic Dysfunction-Associated steatotic liver disease (MASLD) in people with diabetes: the need for screening and early intervention","author":"KC Mf","year":"2025","unstructured":"Mf KC, Cm A, Rr AKB. B, D B, et al. Metabolic Dysfunction-Associated steatotic liver disease (MASLD) in people with diabetes: the need for screening and early intervention. PubMed: A Consensus Report of the American Diabetes Association; 2025."},{"key":"4649_CR21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/JPER.18-0183","volume":"90","author":"SSY ALHarthi","year":"2019","unstructured":"ALHarthi SSY, Natto ZS, Midle JB, Gyurko R, O\u2019Neill R, Steffensen B. Association between time since quitting smoking and periodontitis in former smokers in the National health and nutrition examination surveys (NHANES) 2009 to 2012. J Periodontol. 2019;90:16\u201325. https:\/\/doi.org\/10.1002\/JPER.18-0183.","journal-title":"J Periodontol"},{"key":"4649_CR22","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth joint National committee (JNC 8). JAMA. 2014;311:507\u201320. https:\/\/doi.org\/10.1001\/jama.2013.284427.","journal-title":"JAMA"},{"key":"4649_CR23","doi-asserted-by":"publisher","unstructured":"American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019;42 Suppl 1:S13\u201328. https:\/\/doi.org\/10.2337\/dc19-S002","DOI":"10.2337\/dc19-S002"},{"key":"4649_CR24","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","author":"National Cholesterol Education Program (NCEP)","year":"2002","unstructured":"National Cholesterol Education Program (NCEP). Expert panel on Detection, Evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III). Third report of the National cholesterol education program (NCEP) expert panel on Detection, Evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III) final report. Circulation. 2002;106:3143\u2013421.","journal-title":"Circulation"},{"key":"4649_CR25","unstructured":"Johnson CL, Paulose-Ram R, Ogden CL, Carroll MD, Kruszon-Moran D, Dohrmann SM et al. National health and nutrition examination survey: analytic guidelines, 1999\u20132010. Vital Health Stat 2. 2013;:1\u201324."},{"key":"4649_CR26","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/hep.29085","volume":"65","author":"PS Dulai","year":"2017","unstructured":"Dulai PS, Singh S, Patel J, Soni M, Prokop LJ, Younossi Z, et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis. Hepatology. 2017;65:1557\u201365. https:\/\/doi.org\/10.1002\/hep.29085.","journal-title":"Hepatology"},{"key":"4649_CR27","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1053\/j.gastro.2020.01.043","volume":"158","author":"RS Taylor","year":"2020","unstructured":"Taylor RS, Taylor RJ, Bayliss S, Hagstr\u00f6m H, Nasr P, Schattenberg JM, et al. Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: A systematic review and Meta-Analysis. Gastroenterology. 2020;158:1611\u2013e162512. https:\/\/doi.org\/10.1053\/j.gastro.2020.01.043.","journal-title":"Gastroenterology"},{"key":"4649_CR28","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.3390\/nu16091381","volume":"16","author":"B Zy\u015bk","year":"2024","unstructured":"Zy\u015bk B, Ostrowska L, Smarkusz-Zarzecka J, Orywal K, Mroczko B, Cwalina U. Evaluation of the diagnostic utility of selected serum adipokines and cytokines in subjects with MASLD-A pilot study. Nutrients. 2024;16:1381. https:\/\/doi.org\/10.3390\/nu16091381.","journal-title":"Nutrients"},{"key":"4649_CR29","doi-asserted-by":"publisher","first-page":"114171","DOI":"10.1016\/j.jpeds.2024.114171","volume":"274","author":"A Heldens","year":"2024","unstructured":"Heldens A, Dupont E, Devisscher L, Buytaert M, Verhelst X, Raevens S, et al. Adipose tissue insulin resistance correlates with disease severity in pediatric metabolic Dysfunction-Associated steatotic liver disease: A prospective cohort study. J Pediatr. 2024;274:114171. https:\/\/doi.org\/10.1016\/j.jpeds.2024.114171.","journal-title":"J Pediatr"},{"key":"4649_CR30","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.3390\/nu12051305","volume":"12","author":"I Kojta","year":"2020","unstructured":"Kojta I, Chaci\u0144ska M, B\u0142achnio-Zabielska A, Obesity. Bioactive Lipids, and adipose tissue inflammation in insulin resistance. Nutrients. 2020;12:1305. https:\/\/doi.org\/10.3390\/nu12051305.","journal-title":"Nutrients"},{"key":"4649_CR31","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1172\/JCI129192","volume":"129","author":"G Marcelin","year":"2019","unstructured":"Marcelin G, Silveira ALM, Martins LB, Ferreira AV, Cl\u00e9ment K. Deciphering the cellular interplays underlying obesity-induced adipose tissue fibrosis. J Clin Invest. 2019;129:4032\u201340. https:\/\/doi.org\/10.1172\/JCI129192.","journal-title":"J Clin Invest"},{"key":"4649_CR32","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1053\/j.gastro.2012.05.049","volume":"143","author":"F Meng","year":"2012","unstructured":"Meng F, Wang K, Aoyama T, Grivennikov SI, Paik Y, Scholten D, et al. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology. 2012;143:765\u2013e7763. https:\/\/doi.org\/10.1053\/j.gastro.2012.05.049.","journal-title":"Gastroenterology"},{"key":"4649_CR33","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/ncpgasthep0186","volume":"2","author":"A Sch\u00e4ffler","year":"2005","unstructured":"Sch\u00e4ffler A, Sch\u00f6lmerich J, B\u00fcchler C. Mechanisms of disease: adipocytokines and visceral adipose tissue\u2013emerging role in nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol. 2005;2:273\u201380. https:\/\/doi.org\/10.1038\/ncpgasthep0186.","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"4649_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acc.2022.03.001","volume":"109","author":"A Gugliucci","year":"2022","unstructured":"Gugliucci A. Biomarkers of dysfunctional visceral fat. Adv Clin Chem. 2022;109:1\u201330. https:\/\/doi.org\/10.1016\/bs.acc.2022.03.001.","journal-title":"Adv Clin Chem"},{"issue":"Suppl 2","key":"4649_CR35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/dom.14651","volume":"24","author":"B Cariou","year":"2022","unstructured":"Cariou B. The metabolic triad of non-alcoholic fatty liver disease, visceral adiposity and type 2 diabetes: implications for treatment. Diabetes Obes Metab. 2022;24(Suppl 2):15\u201327. https:\/\/doi.org\/10.1111\/dom.14651.","journal-title":"Diabetes Obes Metab"},{"key":"4649_CR36","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00125-011-2401-4","volume":"55","author":"L Serrano-Marco","year":"2012","unstructured":"Serrano-Marco L, Barroso E, El Kochairi I, Palomer X, Michalik L, Wahli W, et al. The peroxisome proliferator-activated receptor (PPAR) \u03b2\/\u03b4 agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells. Diabetologia. 2012;55:743\u201351. https:\/\/doi.org\/10.1007\/s00125-011-2401-4.","journal-title":"Diabetologia"},{"key":"4649_CR37","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.3390\/diagnostics14222478","volume":"14","author":"T Sarkar Das","year":"2024","unstructured":"Sarkar Das T, Meng X, Abdallah M, Bilal M, Sarwar R, Shaukat A. An assessment of the Feasibility, patient Acceptance, and performance of Point-of-Care transient elastography for Metabolic-Dysfunction-Associated steatotic liver disease (MASLD): A systematic review and Meta-Analysis. Diagnostics (Basel). 2024;14:2478. https:\/\/doi.org\/10.3390\/diagnostics14222478.","journal-title":"Diagnostics (Basel)"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04649-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04649-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04649-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:28:10Z","timestamp":1771511290000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04649-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4649"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04649-0","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"21 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The NHANES protocol was approved by the National Center for Health Statistics (NCHS) Research Ethics Review Board. All participants provided written informed consent. As this study used de-identified, publicly available data, additional ethical approval was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This manuscript does not contain any individual person\u2019s data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"139"}}